|
|
|||||||||||||||
|
Biomyx Technology, is a private
biotechnology company located in the beautiful Novel technologies being developed at Biomyx
include D-siRNAä and ProLinkä. D-siRNAä is fast, straightforward and far more superior to currently available
RNA interference technologies. It can be used to efficiently knock down expression
of specific genes in mammalian cells with small interfering ribonucleic acid
(siRNA). Gene-specific siRNA expression vectors are also under development. ProLinkä is a new technology allows site-specific protein
and/or peptide ligation and labeling with known stoichimetry. It’s the ideal
technology for directly studying protein functions and for improving proteins
of diagnostic and therapeutic values. Furthermore, Biomyx also offers ready-to-use
research tools and services. The ProteGeneä product
line are ready-to-use, gene-specific reagents
that inhibit or activate gene expression of important signaling molecules
such as dominant negative and constitutively active mutants of all 4 isoforms
of human small G protein Ras and other oncogenes and tumor suppressors.
Biomyx has extensive expertise and experience on various aspects of
biosciences including molecular biology, cell biology and biochemistry, and
hence offers molecular biology and biochemistry services on a fee-for-service
basis upon request. Lastly, Biomyx makes and markets Redi-Plateä, Prepoured Agar Plates for yeast and E. coli.
These high-quality, cost effective prepoured agar plates not only save many
hours of researchers’ time but also free their minds for more creative
thinking. |
||||||||||||||
|
ã2002 Biomyx
Technology · |